The beer belly is not really about the beer
Blame the beer if you like, but the research does not. Studies find that beer raises overall body weight without steering fat toward the abdomen. The…
Category: Health & Fitness
The first new painkiller in 20 years comes with a two-week limit
There is one, and it is real. The Food and Drug Administration approved suzetrigine, sold as Journavx, in January 2025 — the first new class of pain…
The cholesterol shot is now a pill
The most powerful cholesterol drugs are not statins. They are PCSK9 inhibitors — and they have been around fas injections for a decade. That changes…
A first-of-its-kind drug for new type 1 diabetes
A diagnosis of type 1 diabetes has always meant the same thing on day one: a lifetime of insulin. A newly approved drug will not…
For older adults, 68 may be the new 62
Living longer is only half the story of aging. A growing body of research suggests that each generation is arriving at older age in better…
A gene-editing therapy reaches the youngest sickle cell patients
September is Sickle Cell Awareness Month, and this year it arrives with a milestone: the first gene therapy for the disease has reached young children.…
How cancer research dollars get divided
You might assume that cancer research money follows the death toll — that the deadliest cancers draw the most funding. The real picture is more…
A smarter way to screen for prostate cancer
For decades, the trouble with prostate cancer screening was not that it missed dangerous tumors. It was that it found too many harmless ones. The…
Who really pays for a $2 million cure?
A one-time gene therapy for sickle cell disease carries a list price of $2.2 million, but almost no patient ever sees that bill. The harder…
Weight-loss drugs may guard the heart’s rhythm
The popular weight-loss and diabetes drugs known as GLP-1 receptor agonists may do something their makers never set out to do: protect the heart from…